EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model

Hacer Kayhan Kaya iD, Berjan Demirtas iD, Beran Yokus iD, Dilek Aygün Kesim iD, Ezel Tasdemir iD, Abdurrahman Sermet iD

Acta Pharmaceutica · 2024

DOI: 10.2478/acph-2024-0001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica, 2024. Verfasst von Hacer Kayhan Kaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Dicle University, Faculty of Medicine Diyarbakır, Turkey. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statin treatment may increase the risk of diabetes; there is insufficient data on how statins affect glucose regulation and glycemic control and the effects of statins on liver enzymes related to carbohydrate metabolism have not been fully studied. Therefore, we aimed to compare the effects of the statin derivatives, pravastatin, and rosuvastatin, on carbohydrate metabolism in an experimental diabetic rat model. Female Wistar albino rats were used and diabetes was induced by intraperitoneal injection of streptozotocin. Thereafter, 10 and 20 mg kg −1 day −1 doses of both pravastatin and rosuvastatin were administered by oral gavage to the diabetic rats for 8 weeks. At the end of the experiment, body masses, the levels of fasting blood glucose, serum insulin, insulin resistance (HOMA-IR), liver glycogen, and liver enzymes related to carbohydrate metabolism were measured. Both doses of pravastatin significantly in creased the body mass in diabetic rats, however, rosuvastatin, especially at the dose of 20 mg kg −1 day −1 reduced the body mass signi ficantly. Pravastatin, especially at a dose of 20 mg kg −1 day −1 , caused significant increases in liver glycogen synthase and glucose 6-phosphate dehydrogenase levels but significant decreases in the levels of glycogen phosphorylase, lactate dehydrogenase, and glucose-6-phosphatase. Hence, pravastatin partially ameliorated the adverse changes in liver enzymes caused by diabetes and, especially at the dose of 20 mg kg −1 day −1 , reduced the fasting blood glucose level and increased the liver glycogen content. However, rosuvastatin, especially at the dose of 20 mg kg −1 day −1 , significantly reduced the liver glycogen synthase and pyruvate kinase levels, but increased the glycogen phosphorylase level in diabetic rats. Rosuvastatin, 20 mg kg −1 day −1 dose, caused significant decreases in the body mass and the liver glycogen content of diabetic rats. It can be concluded that pravastatin, especially at the dose of 20 mg kg −1 day −1 is more effective in ameliorating the negative effects of diabetes by modulating carbohydrate metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsDiabetes Mellitus, ExperimentalFemaleRatsAnimalsBlood GlucoseRats, WistarRosuvastatin CalciumPravastatinHypoglycemic AgentsGlycogen SynthaseLiver GlycogenGlycated HemoglobinGlucoseCarbohydrate MetabolismGlycogen PhosphorylaseLiverInsulin

Stichwörter der Autor:innen

diabetes mellituspravastatinratrosuvastatinstreptozotocin

Substanzen

Blood GlucoseRosuvastatin CalciumPravastatinHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsGlycogen SynthaseLiver GlycogenGlycated HemoglobinGlucoseGlycogen Phosphorylase

Autor:innen und Institutionen

  • Department of Physiology, Dicle University, Faculty of Medicine Diyarbakır, Turkey.
  • Plant and Animal Production Department, Equine and Training Program, Vocational School of Veterinary Medicine, İstanbul University-Cerahpaşa, İstanbul, Turkey.
  • Department of Biochemistry Faculty of Veterinary Medicine Dicle University Diyarbakır Turkey.
  • Department of Physical Medicine and Rehabilitation, Dicle University, Faculty of Medicine Diyarbakır, Turkey.
  • Department of Internal Medicine Medicalpark Hospitals, Antalya Turkey.

ORCID-Profile: Hacer Kayhan Kaya, Berjan Demirtas, Beran Yokus, Dilek Aygün Kesim, Ezel Tasdemir, Abdurrahman Sermet

Zitieren

APA

Kaya, H. K., Demirtas, B., Yokus, B., Kesim, D. A., Tasdemir, E., & Sermet, A. (2024). Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model. Acta Pharmaceutica. https://doi.org/10.2478/acph-2024-0001

Vancouver

Kaya HK, Demirtas B, Yokus B, Kesim DA, Tasdemir E, Sermet A. Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model. Acta Pharmaceutica. 2024. doi:10.2478/acph-2024-0001

BibTeX
@article{Kaya2024,
  author = {Kaya, Hacer Kayhan and Demirtas, Berjan and Yokus, Beran and Kesim, Dilek Aygün and Tasdemir, Ezel and Sermet, Abdurrahman},
  title = {Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model},
  journal = {Acta Pharmaceutica},
  year = {2024},
  doi = {10.2478/acph-2024-0001}
}
Kostenlos starten →